Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Completed · Phase 2
Conditions studied: Ovarian Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus peripheral stem cell transplantation in treating patients with stage III or stage IV ovarian epithelial cancer.
Key facts
- Study ID
- NCT00003413
- Run by
- University of Maryland, Baltimore
- People needed
- 32
- Starts
- 1998-09-01
- Expected to finish
- 2001-02-01
- Last updated by the study team
- 2019-10-17
Who can join
Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.